Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gliatech

This article was originally published in The Gray Sheet

Executive Summary

Relaunch of Adcon-L outside the U.S. is slated for June 2001, assuming completion of manufacturing validation runs, company announces April 18. Gliatech has received a recommendation for ISO 9001 recertification following a successful European audit. The company recalled its Adcon-T/N and Adcon-L gel lines in January due to a supplier recall (1"The Gray Sheet" Jan. 15, 2001, p. 23). U.S. relaunch of Adcon-L is contingent on "submission and approval of the additional data identified as part of the FDA's Application Integrity Policy status," the release notes

Related Content

UsernamePublicRestriction

Register

MT014772

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel